Stock listing

QURE Stock Price, News, Filings & Events — Uniqure N.v.

Selected listing: QURE · NASDAQ · USD · US

This page tracks Uniqure N.v.'s QURE:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following QURE:NASDAQ. QURE:NASDAQ is the stock-level entry point for investors researching Uniqure N.v., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Uniqure N.V. is a public company traded on the American market under the ticker QURE. With a market capitalization of approximately $2.74 billion, Uniqure focuses on developing gene therapies for genetic diseases. The company is committed to advancing innovative treatment options to improve patient outcomes.

QURE:NASDAQUSDUSUpdated July 31, 2026
Uniqure N.v. logo
Ticker
QURE:NASDAQ
Asset type
Stock
Market cap
$3.03B
Sector
Health Technology
Industry
Biotechnology
Exchange
NASDAQ
Currency
USD

Uniqure N.v. QURE:NASDAQ stock context

This page tracks Uniqure N.v.'s QURE:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following QURE:NASDAQ. QURE:NASDAQ is the stock-level entry point for investors researching Uniqure N.v., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Uniqure N.V. is a public company traded on the American market under the ticker QURE. With a market capitalization of approximately $2.74 billion, Uniqure focuses on developing gene therapies for genetic diseases. The company is committed to advancing innovative treatment options to improve patient outcomes.

Latest news from Uniqure N.v.

All Uniqure N.v. news →

Uniqure N.v. earnings calls

Research Uniqure N.v.

Alternate listings